CardioExchange Archive

February 13th, 2015

Can Clopidogrel Get Along with Proton Pump Inhibitors?

CardioExchange Editors, Staff

Are there clinically significant interactions between clopidogrel, proton pump inhibitors, and other drugs?

---

May 18th, 2014

Statins Disappoint In COPD And ARDS

Larry Husten, PHD

Two NHLBI studies have failed to find any benefit for statin therapy in patients with chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS). Previous observational studies had raised the possibility that statins, perhaps due to their anti-inflammatory effects, might improve outcomes in people with these serious diseases. But both trials were stopped early by […]

---

December 10th, 2013

Co-Chairs of CVD Risk Guidelines Discuss a Difficult Case

Eric Lindley, MD, Donald M Lloyd-Jones, MD, ScM and David C. Goff, Jr., MD, PhD

Fellow Eric Lindley presents a challenging case to David Goff and Donald Lloyd-Jones, co-chairs of the new 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk.

---

July 22nd, 2010

HDL and Residual Risk: A Surprising Finding in JUPITER

Larry Husten, PHD

CardioExchange welcomes Dr. Paul Ridker to answer questions about his recent paper in the Lancet, which analyzed data from JUPITER and found that HDL may not predict residual risk in patients on high-dose statins who reach very low LDL levels such as those achieved in the treatment group in JUPITER. The findings may surprise some readers, though […]

---